Sarcoma trials in China
106 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in ChinaAdjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 88
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT06041490 - Phase 2Taking peopleLenvatinib for Advanced Bone and Soft Tissue Sarcoma
- Where
- Zhengzhou
- Age
- 10 years to 70 years
- People
- 60
- Run by
- Henan Cancer Hospital
See details and how to joinNCT05617859 - Phase 1/2Taking peopleThe Combination of Radiotherapy，Surufatinib and Sintilimab in High-Risk Localized Soft Tissue Sarcoma
- Where
- Shanghai
- Age
- 18 years to 70 years
- People
- 52
- Run by
- Fudan University
See details and how to joinNCT05839275 - Phase 4Enrolling by invitationNeoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma
- Where
- Beijing, Qingdao, Shanghai, Xi’an
- Age
- 18 years to 75 years
- People
- 102
- Run by
- Peking University International Hospital
See details and how to joinNCT05844813 - No phaseTaking peopleStudy of NY-ESO-1 TCR-T in Advanced Soft Tissue Sarcoma
- Where
- Shenzhen
- Age
- 18 years to 70 years
- People
- 20
- Run by
- Shenzhen University General Hospital
See details and how to joinNCT05620693 - Phase 1/2Not yet taking people in ChinaA Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma
- Where
- Beijing, Jinan, Shanghai
- Age
- 2 years to 25 years
- People
- 148 worldwide
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT05590572